Callori Fred 4

4 · CATABASIS PHARMACEUTICALS INC · Filed Jun 2, 2021

Insider Transaction Report

Form 4
Period: 2021-06-02
Callori Fred
Director
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-02+85,00085,000 total
    Exercise: $2.04Exp: 2031-06-01Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]This option was granted on June 2, 2021 and is schedule to vest in equal annual installments over a three-year period from the date of grant, subject to the director's continued service.

Documents

1 file
  • 4
    tm2118270-10_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT